A meta-analysis finds less pain with manual eyelid retraction than with a speculum and fewer complications with device-assisted techniques. Medscape Medical News
Author: Medscape
AAO 2026
Read clinically focused news coverage of key developments from AAO 2026. Medscape Ophthalmology
Can Anti-VEGF Cause More Complications in DME Patients?
A study of more than 40,000 diabetic patients found the injectable treatment associated with a nearly threefold increased risk for ocular hypertension or glaucoma over 5 years. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Switch to Faricimab May Extend Dosing Intervals in nAMD
Switching from aflibercept to faricimab is linked to longer dosing intervals and better fluid control over 3 years among patients with treatment-resistant neovascular age-related macular degeneration. Medscape Medical News
Drusen Type Tied to Atrophy, Not Anti-VEGF Response
A study finds drusen type is linked to macular atrophy risk in wet AMD, but not to how well eyes respond to anti-VEGF treatment. Medscape Medical News
Statins Tied to Lower Risk for Glaucoma, Fewer Procedures
Statin use is associated with a 15% lower risk of developing open-angle glaucoma at 5 years and with lower rates of laser and surgical procedures among patients already diagnosed with the condition. Medscape Medical News
Glaukos Says Late-stage Eye Disease Treatment Shows Lasting Benefits After Single Dose
Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a single treatment… Reuters Health Information
Staying on Aspirin Seen Mostly Safe in Vitreoretinal Surgery
A meta-analysis finds staying on aspirin therapy did not necessarily raise the risk for ocular bleeding complications during vitreoretinal surgery. Medscape Medical News
Concert Laser Unmasks Eye Condition: EURETINA Case Reports
A laser reveals hidden vascular pathology, ocular findings signal cancer recurrence, and a possible link between eating disorders and retinal hemorrhage. Medscape Medical News
Early Pegcetacoplan Use Preserves More Retina in GA
Five-year data show pegcetacoplan slows geographic atrophy, with earlier treatment preserving more retinal tissue than delayed treatment. Medscape Medical News
Smartphone 3D Tool May Improve Ptosis Assessment
A smartphone-based 3D tool measures eyelid droop as accurately as specialists and may help clinicians decide which patients need surgery. Medscape Medical News
Retinal Thinning Seen Below Prediabetes A1c Threshold
Retinal neurodegenerative changes were associated with A1c levels below the current threshold for prediabetes, UK Biobank data show. Medscape Medical News
Conference MDAngle: AAO 2026 Wet Age-Related Macular Degeneration
Upcoming presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and personalized anti-VEGF therapy. Medscape
AAO 2026 Preview: Emerging Therapies for Wet AMD
Anticipated presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and individualized anti-VEGF therapy. Medscape
EURETINA 2026
Read clinically focused news coverage of key developments from EURETINA 2026. Medscape Ophthalmology
Extraintestinal Manifestations of UC: 5 Things to Know
Experts share practical guidance on recognizing extraintestinal manifestations and coordinating care for patients with ulcerative colitis. Medscape Gastroenterology
Erectile Dysfunction Pills and Diabetic Eyes: A Link?
Among men aged 50 years or older with diabetes and erectile dysfunction, the use of erectile dysfunction drugs was associated with a lower rate of developing proliferative diabetic retinopathy. Medscape Medical News
Rapid Dry Eye Relief With Investigational Reproxalap Drop
An investigational eye drop relieves symptoms of dry eye disease as early as week 1 in a pooled analysis of two trials, with mild irritation at the drop site being the most common side effect. Medscape Medical News
Age Affects Dupilumab’s Quality-of-Life Benefits in Kids
Dupilumab appears to improve young children’s eczema, but they experience more itching and skin irritation than older children and teens. Medscape Medical News